1.08
price down icon1.82%   -0.02
after-market Dopo l'orario di chiusura: 1.10 0.02 +1.85%
loading
Precedente Chiudi:
$1.10
Aprire:
$1.1
Volume 24 ore:
514.81K
Relative Volume:
1.11
Capitalizzazione di mercato:
$83.01M
Reddito:
-
Utile/perdita netta:
$-73.79M
Rapporto P/E:
-0.587
EPS:
-1.84
Flusso di cassa netto:
$-77.44M
1 W Prestazione:
-15.62%
1M Prestazione:
-10.74%
6M Prestazione:
-30.77%
1 anno Prestazione:
-66.25%
Intervallo 1D:
Value
$1.07
$1.1197
Intervallo di 1 settimana:
Value
$1.07
$1.32
Portata 52W:
Value
$0.8332
$5.3899

Pyxis Oncology Inc Stock (PYXS) Company Profile

Name
Nome
Pyxis Oncology Inc
Name
Telefono
(617) 221-9059
Name
Indirizzo
321 HARRISON AVENUE, BOSTON
Name
Dipendente
44
Name
Cinguettio
Name
Prossima data di guadagno
2024-08-11
Name
Ultimi documenti SEC
Name
PYXS's Discussions on Twitter

Confronta PYXS con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PYXS
Pyxis Oncology Inc
1.08 83.01M 0 -73.79M -77.44M -1.84
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
452.16 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
534.91 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.06 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
542.47 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
245.16 28.51B 3.81B -644.79M -669.77M -6.24

Pyxis Oncology Inc Stock (PYXS) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-21 Downgrade William Blair Outperform → Mkt Perform
2024-11-08 Iniziato Stephens Overweight
2024-08-08 Iniziato Stifel Buy
2024-05-07 Ripresa Jefferies Buy
2024-02-09 Iniziato BTIG Research Buy
2024-01-23 Iniziato Leerink Partners Outperform
2023-09-05 Iniziato RBC Capital Mkts Outperform
2021-11-02 Iniziato BofA Securities Neutral
2021-11-02 Iniziato Credit Suisse Outperform
2021-11-02 Iniziato Jefferies Buy
Mostra tutto

Pyxis Oncology Inc Borsa (PYXS) Ultime notizie

pulisher
Jun 18, 2025

Pyxis Oncology shareholders elect three directors at annual meeting - Investing.com

Jun 18, 2025
pulisher
Jun 18, 2025

Pyxis Oncology Elects New Directors at Annual Meeting - TipRanks

Jun 18, 2025
pulisher
Jun 16, 2025

Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World

Jun 16, 2025
pulisher
Jun 08, 2025

Ameriprise Financial Inc. Takes $35,000 Position in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

Jun 08, 2025
pulisher
Jun 08, 2025

Jane Street Group LLC Grows Stake in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Nuveen Asset Management LLC Cuts Stake in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Pyxis Oncology, Inc. (NASDAQ:PYXS) Shares Sold by Deutsche Bank AG - Defense World

Jun 05, 2025
pulisher
Jun 05, 2025

ProShare Advisors LLC Makes New Investment in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

Jun 05, 2025
pulisher
May 31, 2025

Northern Trust Corp Sells 15,449 Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

May 31, 2025
pulisher
May 30, 2025

Pyxis Oncology Reports Increased Losses Amidst Ongoing R&D Investments - TipRanks

May 30, 2025
pulisher
May 29, 2025

Millennium Management LLC Has $4.65 Million Stock Holdings in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

May 29, 2025
pulisher
May 25, 2025

Pyxis Oncology, Inc. (NASDAQ:PYXS) Receives $9.00 Consensus PT from Analysts - Defense World

May 25, 2025
pulisher
May 22, 2025

HC Wainwright Weighs in on Pyxis Oncology Q1 Earnings - Defense World

May 22, 2025
pulisher
May 22, 2025

Q2 EPS Estimates for Pyxis Oncology Cut by HC Wainwright - Defense World

May 22, 2025
pulisher
May 20, 2025

Leerink Partnrs Comments on Pyxis Oncology FY2029 Earnings - Defense World

May 20, 2025
pulisher
May 20, 2025

Pyxis Oncology’s (PYXS) “Buy” Rating Reaffirmed at HC Wainwright - Defense World

May 20, 2025
pulisher
May 19, 2025

Pyxis Oncology (PYXS) Receives Reiterated Buy Rating from Analys - GuruFocus

May 19, 2025
pulisher
May 18, 2025

Dimensional Fund Advisors LP Raises Position in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

May 18, 2025
pulisher
May 16, 2025

Pyxis Oncology : May 2025 Corporate Deck (9474da) - marketscreener.com

May 16, 2025
pulisher
May 15, 2025

Pyxis Oncology Reports Q1 Loss and Business Update - TipRanks

May 15, 2025
pulisher
May 15, 2025

Pyxis Oncology (PYXS) Advances Cancer Treatment Research | PYXS Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Pyxis Oncology, Inc. SEC 10-Q Report - TradingView

May 15, 2025
pulisher
May 15, 2025

Pyxis Oncology Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 15, 2025
pulisher
May 15, 2025

Pyxis Oncology : May 2025 Corporate Deck (c8a9bd) - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Pyxis Oncology Reports First Quarter 2025 Financial Results and Provides Business Update - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Pyxis Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Barclays PLC Purchases 12,924 Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

May 15, 2025
pulisher
May 14, 2025

Pyxis Oncology to Participate in Two Upcoming Investor Conferences - The Manila Times

May 14, 2025
pulisher
May 14, 2025

Pyxis Oncology, Inc. CEO Lara S. Sullivan to Participate in Upcoming Investor Conferences - Nasdaq

May 14, 2025
pulisher
May 14, 2025

Next-Gen Cancer Drug Developer Pyxis Oncology Sets Major Investor Conference Schedule for May-June - Stock Titan

May 14, 2025
pulisher
May 11, 2025

Pyxis Oncology (PYXS) Projected to Post Quarterly Earnings on Tuesday - Defense World

May 11, 2025
pulisher
May 07, 2025

New Approaches to Tumor Targeting Are Driving the Next Wave of Oncology Breakthroughs - Baystreet.ca

May 07, 2025
pulisher
May 04, 2025

Renaissance Technologies LLC Acquires 133,018 Shares of Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

May 04, 2025
pulisher
May 01, 2025

Pyxis Oncology Inc (PYXS) is a good investment, but the stock may be overvalued - uspostnews.com

May 01, 2025
pulisher
May 01, 2025

Taking a look at what insiders are doing to gauge the Pyxis Oncology Inc (PYXS)’s direction - knoxdaily.com

May 01, 2025
pulisher
Apr 25, 2025

Pyxis Oncology reveals promising preclinical data for cancer drug - Investing.com

Apr 25, 2025
pulisher
Apr 25, 2025

Pyxis Oncology reveals promising preclinical data for cancer drug By Investing.com - Investing.com UK

Apr 25, 2025
pulisher
Apr 25, 2025

Pyxis Oncology Highlights Promising Preclinical Data for Micvotabart Pelidotin (MICVO) in Cancer Therapy at AACR 2025 - Nasdaq

Apr 25, 2025
pulisher
Apr 25, 2025

Pyxis Oncology Presents Promising Preclinical Results Providing Proof of Mechanism of Micvotabart Pelidotin, the First-in-Concept Extracellular-Targeting ADC - TradingView

Apr 25, 2025
pulisher
Apr 25, 2025

Novel Cancer Drug Shows 91% Tumor Inhibition in Breakthrough Study | PYXS Stock News - Stock Titan

Apr 25, 2025
pulisher
Apr 24, 2025

Zacks Industry Outlook Highlights Aurinia Pharmaceuticals, Heron Therapeutics, Esperion Therapeutics, Pyxis Oncology and Plus Therapeutics - Zacks Investment Research

Apr 24, 2025
pulisher
Apr 24, 2025

Pyxis Oncology Inc (PYXS) requires closer examination - uspostnews.com

Apr 24, 2025
pulisher
Apr 23, 2025

5 Small Drug Stocks to Buy as Tariff-Related Uncertainty Looms - Yahoo Finance

Apr 23, 2025
pulisher
Apr 23, 2025

Pyxis Oncology Inc (PYXS) receives a Mkt perform rating from William Blair - knoxdaily.com

Apr 23, 2025
pulisher
Apr 22, 2025

Pyxis Oncology Inc (PYXS) Stock: A Year of Highs and Lows in the Market - investchronicle.com

Apr 22, 2025
pulisher
Apr 17, 2025

Pyxis Oncology, Inc. (NASDAQ:PYXS) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World

Apr 17, 2025
pulisher
Apr 16, 2025

Top Cancer Stocks to Buy to Boost Your Portfolio's Health - Yahoo Finance

Apr 16, 2025
pulisher
Apr 15, 2025

Layoff Tracker: Mural Oncology Cuts 90% of Staff, Explores Strategic Alternatives - BioSpace

Apr 15, 2025
pulisher
Apr 13, 2025

Sei Investments Co. Acquires New Position in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

Apr 13, 2025
pulisher
Apr 13, 2025

American Century Companies Inc. Has $468,000 Stake in Pyxis Oncology, Inc. (NASDAQ:PYXS) - Defense World

Apr 13, 2025
pulisher
Apr 08, 2025

Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Pyxis Oncology, Inc. (NASDAQ:PYXS) - marketscreener.com

Apr 08, 2025

Pyxis Oncology Inc Azioni (PYXS) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.74
price up icon 0.39%
$35.88
price down icon 0.42%
$21.20
price down icon 0.38%
$97.62
price down icon 3.00%
$107.51
price up icon 0.98%
biotechnology ONC
$245.16
price up icon 1.28%
Capitalizzazione:     |  Volume (24 ore):